Ian F. Smith, EVP & CFO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 378 shares at $123.85 ($47K) on 2015-05-15, disclosed to the SEC on 2015-05-18.
Scheduled sale ($47k) by EVP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $123.85 | 100 | $12K | 26.1% |
| 2 | $125.84 | 178 | $22K | 47.2% |
| 3 | $126.99 | 100 | $13K | 26.7% |
| Total | $125.62 avg | 378 | $47K | 100% |
| Filing → |
| ACOR | SELL | 2018-06-19 | $786K | — | Filing → |
| VRTX | SELL | 2018-05-16 | $34K | — | Filing → |
| VRTX | SELL | 2018-05-15 | $635K | — | Filing → |